Immune Thrombocytopenia(ITP) Clinical Trials
2 recruiting trials for Immune Thrombocytopenia(ITP). Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGEarly Phase 1NCT07174843
An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases
This is a single arm, open-label, dose escalation and expansion study to evaluate the safety, tolerability and preliminary efficacy of autologous chimeric antigen receptor T...
Sponsor: Shanghai Cell Therapy Group Co.,LtdEnrolling: 201 location
RECRUITINGPhase 1NCT06371417
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
This Phase 1b basket trial will investigate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity and preliminary efficacy of RAY121, a inhibitor of...
Sponsor: Chugai PharmaceuticalEnrolling: 14420 locations